ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 82.85% of HARP shares are held by financial institutions. NEW LEAF VENTURE PARTNERS, L.L.C. is the top corporate investor, holding 1.86M shares valued at $21.14M. A 47.09% stake in Harpoon Therapeutics, Inc. is owned by the company. MPM ASSET MANAGEMENT LLC owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.
Among the HARP insiders holding of 0.35% of the stake in company, GADICKE ANSBERT, 10 percent owner, holds the largest shares of 6.33M. MPM BIOVENTURES 2014, L.P., , is the second largest HARP insider with ownership of 3.22M shares. NEW LEAF VENTURES III, L.P., 10 percent owner, stands third with possession of 913.86K shares of that stake.